Home / World Marketplace / Archive by category Global Lifestyle (Page 169)

Archive by category Global Lifestyle

Global Polo Entertainment Extends Historic Agreement with ESPN Through 2024 to Broaden Access to the Action-Packed Sport of Polo, Presented by U.S. Polo Assn.

WEST PALM BEACH, Fla., Jan. 10 (Korea Bizwire) — Global Polo Entertainment (GPE), the entertainment and media subsidiary of USPA Global Licensing Inc. (USPAGL), has extended their historic relationship with ESPN for two additional years beginning Jan. 1, 2023. USPAGL manages U.S. Polo Assn., the official brand of the United States Polo Association (USPA), the governing [...]

Newly Launched Travel Website comperk.com Makes Getting Complimentary Luxury Hotel Perks Easy and Convenient

LOS ANGELES, Jan. 10 (Korea Bizwire) — Social media feeds are filled with influencers showing off their luxury travel lifestyles. From incredible hotel rooms that overlook the Amalfi coast, and gourmet meals in Hong Kong, to relaxing spa experiences at 5-star hotel properties, getting inspired by incredible experiences in exotic locals is easier than ever. [...]

Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors

Mont-Saint-Guibert, Belgium, Jan. 9 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it has appointed Mr. Daniel Wildman as an Independent Director to its Board of Directors*. Mr. Wildman is [...]

ENA Respiratory Awarded $4.38 Million U.S. Department of Defense Agreement to Fund Development of Broad-Spectrum Antiviral INNA-051

MELBOURNE, Australia, Jan. 9 (Korea Bizwire) — Clinical-stage pharmaceutical company ENA Respiratory has been awarded a $4.38 million USD agreement from the U.S. Department of Defense (DoD) to support ongoing research and development of INNA-051, a clinical stage first-in-class broad-spectrum antiviral innate immunomodulator, administered intranasally for the prophylaxis of respiratory viral infections and their complications. The agreement [...]

Health-ISAC Introduces New Logo and Branding

ORMOND BEACH, Fla., Jan. 9 (Korea Bizwire) – Health-ISAC, a nonprofit, member driven organization, has unveiled a new logo and branding scheme to reflect its commitment to ensuring the strength and perseverance of the health sector in the face of both cyber and physical threats. The new logo demonstrates the key role Health-ISAC has in the global [...]

STALICLA Signs Exclusive In-licensing Agreement for Late-stage Clinical Neuropsychiatric and Neurodevelopmental Disorder Treatment

Geneva, SWITZERLAND, Jan. 9 (Korea Bizwire) – STALICLA SA, a clinical-stage biotech company advancing the first precision neurobiology platform for patients with neurodevelopmental disorders, today announced that it has entered into an exclusive in-licensing agreement with Novartis to develop mavoglurant as a treatment for substance-use disorder and neurodevelopmental disorders (NDDs). Mavoglurant has previously been tested in more than 1,800 [...]

Minovia Therapeutics Appoints Maha Radhakrishnan, Chief Medical Officer at Biogen, as Board Member

TIRAT HACARMEL, Israel, Jan. 5 (Korea Bizwire) – Minovia Therapeutics (Minovia), a clinical-stage company focused on developing novel Mitochondrial Augmentation Technology (MAT) to fight mitochondrial diseases, has announced a Board appointment. Maha Radhakrishnan, M.D., joins the board at a time in which the company advances clinical programs in primary mitochondrial diseases and hematological disorders associated with mitochondrial dysfunction. As a [...]

AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma

SINGAPORE and BETHESDA, Md., Jan. 5 (Korea Bizwire) — AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotech company focused on discovering and developing precision oncology therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted a Rare Pediatric Disease Designation (RPDD) for its product candidate, AUM302, a potential first-in-class oral kinase [...]

Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study

Boca Raton, FL, Jan. 5 (Korea Bizwire) — Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for rare diseases and conditions, announced today that it has successfully completed its Investigational New Drug (IND) enabling Tolerance and Toxicology Study of Metformin HCL Solution by Topical Instillation [...]

Herbalife Nutrition Virtual Run 2022 Records 15,000 Participants Clocking More Than 1 Million Kilometers, Equivalent to Running Around the World 26 Times

HONG KONG SAR, Jan. 5 (Korea Bizwire) – Premier global nutrition company, Herbalife Nutrition, today announced the results of its 2022 Virtual Run, an annual event aimed at helping people in Asia Pacific get moving with a healthy active lifestyle. Held from November 1 to 30, over 15,000 participants from the public, as well as Herbalife [...]